This statistic shows the distribution of generic drugs in the French pharmaceutical market in 2018, according to value and volume. The share of generic molecules in the pharmaceutical market accounted for about 70 percent of the total value of the pharmaceutical market for drugs listed by the ANSM.
Distribution of generic drugs in the French pharmaceutical market in 2018, according to value and volume
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Generics and biosimilars in Italy
Global overview
6
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Basic Statistic Value share of pharmaceutical subsectors worldwide 2003 vs. 2021
- Basic Statistic Generic drugs market size worldwide 2022-2030
- Premium Statistic Revenues of leading global generics manufacturers 2022
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
Generic drugs overview
7
- Premium Statistic Share of pharmaceutical drugs market value in Italy 2018-2023, by type
- Premium Statistic Growth rate of generic drugs market value sold by pharmacies in Italy 2017-2022
- Premium Statistic Share of pharmaceutical drugs market volume in Italy 2018-2023, by type
- Premium Statistic Growth rate of generic drugs market volume in Italy 2017-2022, by quarter
- Basic Statistic Generic market share volume in community pharmacies in Italy 2012-2022
- Premium Statistic Difference in price between brand drugs and generics in Italy 2021, by region
- Premium Statistic Trends in generic drugs consumption in hospitals in Italy 2009-2023
Generics' expenditure
5
- Premium Statistic Share of generics on public pharmaceutical expenditure in Italy 2022, by region
- Premium Statistic Share of net expenditures for generic drugs in Italy 2018-2023, by geographical area
- Premium Statistic Class A generic drugs distribution expenditure in Italy 2023, by active ingredient
- Premium Statistic Class C generic drugs expenditure distribution in Italy by active ingredient 2023
- Premium Statistic Distribution of hospital expenditure on drugs in Italy by patent status 2023
Generics' consumption
3
Biosimilar drugs
5
- Premium Statistic Share of consumption of biosimilar drugs in Italy 2016-2022
- Premium Statistic Consumption volume of biosimilar drugs in Italy 2016-2022
- Premium Statistic Italy: estimated market value of biosimilars 2018-2022, by type
- Premium Statistic Share of biosimilars on the total marketed products in Italy in 2022, by molecule
- Premium Statistic Share of biosimilars consumed over all biosimilars molecules in Italy 2022, by region
Outlook
5
- Basic Statistic Worldwide generic prescription drug sales 2012-2026
- Basic Statistic Global generic prescription drug revenues as share of prescribed revenue 2012-2026
- Basic Statistic Opportunities worldwide to develop generics, by therapeutic area 2020-2026
- Premium Statistic Patent expiration risks for total worldwide prescription drug revenue 2023-2028
- Premium Statistic CAGR of the biosimilars market in Europe and the United States 2018-2025
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
LEEM. (September 16, 2019). Distribution of generic drugs in the French pharmaceutical market in 2018, according to value and volume [Graph]. In Statista. Retrieved June 13, 2024, from https://www.statista.com/statistics/753465/market-share-of-generic-drugs-france/
LEEM. "Distribution of generic drugs in the French pharmaceutical market in 2018, according to value and volume." Chart. September 16, 2019. Statista. Accessed June 13, 2024. https://www.statista.com/statistics/753465/market-share-of-generic-drugs-france/
LEEM. (2019). Distribution of generic drugs in the French pharmaceutical market in 2018, according to value and volume. Statista. Statista Inc.. Accessed: June 13, 2024. https://www.statista.com/statistics/753465/market-share-of-generic-drugs-france/
LEEM. "Distribution of Generic Drugs in The French Pharmaceutical Market in 2018, According to Value and Volume." Statista, Statista Inc., 16 Sep 2019, https://www.statista.com/statistics/753465/market-share-of-generic-drugs-france/
LEEM, Distribution of generic drugs in the French pharmaceutical market in 2018, according to value and volume Statista, https://www.statista.com/statistics/753465/market-share-of-generic-drugs-france/ (last visited June 13, 2024)
Distribution of generic drugs in the French pharmaceutical market in 2018, according to value and volume [Graph], LEEM, September 16, 2019. [Online]. Available: https://www.statista.com/statistics/753465/market-share-of-generic-drugs-france/